Harvard Bioscience is a global developer, manufacturer and marketer of life sciences equipment to support research and drug discovery. It is traded on NASDAQ under the stock symbol HBIO. Headquartered in Holliston, Massachusetts, United States, the company has 20 wholly owned subsidiaries. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Harvard Bioscience (United States), United States, covering academic research published from 2001 to 2023. Read More.
Open Access Percentage
86%
Total
Publications
104
Total Open
Publications
89
Total
Citations
6.2K
Open Access
Percentage
86%
Total
Publications
104
Total Open
Publications
89
Total
Citations
6.2K
Breakdown
Publisher Open
10%
Both
45%
Other Platform Open
31%
Closed
14%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 32%
18
Hybrid 42%
24
No Guarantees 26%
15
Other Platform Open
Domain 71%
56
Institution 39%
31
Preprint 25%
20
Other Internet 16%
13
Public 9%
7
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | Domain | 56 |
Europe PMC | Domain | 46 |
DOI | Other Internet | 29 |
bioRxiv | Preprint | 19 |
Harvard University - Digital Access to Scholarship at Harvard (DASH) | Institution | 16 |
Massachusetts Institute of Technology - DSpace@MIT | Institution | 9 |
University of Groningen / Centre for Information Technology - University of Groningen research database | Institution | 8 |
Semantic Scholar | Public | 4 |
Figshare | Public | 4 |
CiteSeer X | Other Internet | 4 |